KM-277

N/A

Report date: 2025/01/26 17:35:48
NME

Base Information

Drug NameKM-277
Drug Alias Nameanti-inflammatory (Cellceutix)anti-inflammatory (Innovation Pharmaceuticals)KM-277
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInnovation Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesInnovation Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A